.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Management of Neuroendocrine Tumors

EP. 1: Neuroendocrine Tumors: Introduction and Overview

March 14th 2013

EP. 2: Histological Classification of Neuroendocrine Tumors

March 14th 2013

EP. 3: The Role of Biomarkers in Neuroendocrine Tumors

March 14th 2013

EP. 4: Challenges in the Diagnosis of Neuroendocrine Tumors

March 14th 2013

EP. 5: Techniques for Diagnosing Neuroendocrine Tumors

March 14th 2013

EP. 6: The Genetics Behind Familial Neuroendocrine Tumors

March 14th 2013

EP. 7: Surgical Treatment of Neuroendocrine Tumors

March 14th 2013

EP. 8: Role of Somatostatin Analogs in Neuroendocrine Tumors

March 14th 2013

EP. 9: Emerging Treatment Options in Neuroendocrine Tumors

March 14th 2013

EP. 10: Targeted Therapies in Neuroendocrine Tumors

March 14th 2013

EP. 11: Treating Neuroendocrine Tumors With Chemotherapy

March 14th 2013

EP. 12: Managing NETs in the Community Setting

March 14th 2013